A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents.

Novo Nordisk has unveiled a new direct-to-patient online pharmacy which will offer Wegovy at less than half its standard ...